Asgpr-binding compounds for the degradation of extracellular proteins
US-2024424108-A1 · Dec 26, 2024 · US
[1,3,4] oxadiazole derivative and application thereof
US8993575B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8993575-B2 |
| Application number | US-201214008693-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 1, 2012 |
| Priority date | Apr 1, 2011 |
| Publication date | Mar 31, 2015 |
| Grant date | Mar 31, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention belongs to the medicinal chemistry field, and specifically discloses a [1,3,4]oxadiazole derivative with the structure of general formula (I) and pharmaceutically acceptable salt thereof. The compound can be used to prepare a medicine for preventing or treating a disease of the central nervous system.
First claim
Opening claim text (preview).
What is claimed: 1. A compound having the general formula (I) or a pharmaceutically acceptable salt thereof, wherein, Q is O, S or N; Y is O or S; Z is N or CH; n is 1, 2 or 3; R1 is H, halogen, cyano, C 1-5 alkoxy, C 1-5 alkyl, said C 1-5 alkyl being unsubstituted or substituted by one or more substituents selected from the group consisting of amino, hydroxyl an…
Assignees
Inventors
Classifications
Chemistry & Metallurgy · mapped topic
- C07D417/12Primary
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8993575B2 cover?
- The present invention belongs to the medicinal chemistry field, and specifically discloses a [1,3,4]oxadiazole derivative with the structure of general formula (I) and pharmaceutically acceptable salt thereof. The compound can be used to prepare a medicine for preventing or treating a disease of the central nervous system.
- Who is the assignee on this patent?
- Zhang Guisen, Chen Yin, Xu Xiangqing, and 9 more
- What technology area does this patent fall under?
- Primary CPC classification C07D417/12. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).